Fresenius SE & Co. KGaA (FSNUY)
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Care Facilities
Fresenius SE & Co. KGaA
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | 14.52 | 14.81 | 14.22 | 14.28 | 131,380 |
| Nov 18, 2026 | 14.76 | 14.85 | 14.66 | 14.68 | 83,359 |
| Nov 17, 2026 | 14.77 | 14.91 | 14.77 | 14.78 | 65,444 |
| Nov 16, 2026 | 14.98 | 15.01 | 14.79 | 14.79 | 77,867 |
| Nov 13, 2026 | 14.80 | 14.85 | 14.79 | 14.80 | 50,077 |
| Nov 12, 2026 | 14.95 | 15.01 | 14.70 | 14.72 | 78,476 |
| Nov 11, 2026 | 14.72 | 14.76 | 14.63 | 14.72 | 69,609 |
| Nov 10, 2026 | 14.98 | 15.03 | 14.89 | 14.99 | 67,900 |
| Nov 9, 2026 | 14.78 | 14.95 | 14.70 | 14.86 | 111,243 |
| Nov 6, 2026 | 14.32 | 14.64 | 14.32 | 14.52 | 80,570 |
| Nov 5, 2026 | 14.48 | 14.79 | 14.42 | 14.42 | 292,391 |
| Nov 4, 2026 | 14.30 | 14.57 | 14.26 | 14.41 | 147,960 |
| Nov 3, 2026 | 13.63 | 13.86 | 13.53 | 13.61 | 90,403 |
| Nov 2, 2026 | 13.67 | 13.71 | 13.47 | 13.56 | 87,463 |
| Oct 30, 2026 | 13.33 | 13.37 | 13.30 | 13.35 | 83,260 |
| Oct 29, 2026 | 13.09 | 13.17 | 12.94 | 13.04 | 79,553 |
| Oct 28, 2026 | 12.90 | 13.01 | 12.81 | 12.86 | 60,091 |
| Oct 27, 2026 | 12.93 | 12.96 | 12.80 | 12.81 | 66,789 |
| Oct 26, 2026 | 13.09 | 13.09 | 12.83 | 12.93 | 100,146 |
| Oct 23, 2026 | 12.88 | 13.03 | 12.68 | 12.88 | 98,691 |
| Name | Shares | % | Source |
|---|---|---|---|
Sterling Capital Management LLC | 14.5K | -- | 13F |
RHUMBLINE ADVISERS | 11.7K | -- | 13F |
GAMMA Investing LLC | 4.1K | -- | 13F |
Calydon Capital | 3.5K | -- | 13F |
PNC FINANCIAL SERVICES GROUP, INC. | 339 | -- | 13F |
First Command Advisory Services, Inc. | 47 | -- | 13F |
Planning Project LLC | 21 | -- | 13F |
HANTZ FINANCIAL SERVICES, INC. | 8 | -- | 13F |
Fresenius SE & Co. KGaA operates as a diverse healthcare enterprise, supplying a comprehensive array of products and services primarily focused on dialysis, hospital management, and outpatient medical care.
Its activities are structured across four main divisions: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care division is dedicated to individuals living with chronic kidney failure, offering essential items like dialyzers, hemodialysis machines, and related disposable supplies, alongside various dialysis-specific services. Fresenius Kabi concentrates on the therapeutic treatment and care of ill patients.
Its extensive product range includes intravenous pharmaceuticals, such as generic drugs for oncology, anesthetics, pain relief, anti-infectives, and critical care.
Additionally, it provides parenteral and enteral nutritional products, infusion solutions, and blood volume expanders for infusion therapy. The segment also develops biosimilars—biological medicines for autoimmune and cancer conditions—and manufactures medical devices and disposables crucial for administering IV generics, infusion treatments, and clinical nutrition. Transfusion products for blood component collection and corporeal therapies are also part of its offerings. Fresenius Helios manages significant healthcare operations, encompassing 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers throughout Germany. In Spain, its presence includes 49 hospitals, 88 outpatient clinics, and around 300 risk prevention centers. This segment also delivers fertility treatment services through 33 clinics and an additional 39 sites located across 10 countries on three continents. Finally, the Fresenius Vamed division specializes in project management and service delivery for hospitals and other healthcare facilities.
Its offerings span project development, meticulous planning, and turnkey construction solutions. Furthermore, it provides ongoing maintenance, technical oversight, and operational management services.
The company, initially known as Fresenius SE, officially changed its name to Fresenius SE & Co. KGaA in January 2011. Founded in 1912, Fresenius SE & Co. KGaA maintains its corporate headquarters in Bad Homburg vor der Höhe, Germany.
based on 9.01B shares outstanding
30d Avg
95.59K
60d Avg
236.67K
90d Avg
188.51K
Fresenius SE & Co. KGaA (OTC: FSNUY) traded at $14.28 on Nov 19, 2026, down 2.72% from the previous close of $14.68. 52-week range: $10.33 to $15.94. The company is in the Healthcare sector (Medical - Care Facilities).